Apeiron Biologics AG

Ligand Pharmaceuticals, Inc. has made its second major oncology investment in two months with the acquisition of Apeiron Biologics AG and the Austrian biotech’s royalty rights for Qarziba (dinutuxi

Founded back in 2012, Exscientia plc went public on Nasdaq in October 2021, raising over $300m – a huge amount for a biotech that is yet to bring a drug into the clinic on its own. However, it was a

The European Medicines Agency has begun a rolling review of another monoclonal antibody (MAb) combination product for the prevention of COVID-19, this time AstraZeneca PLC ’s Evusheld, which contains

The UK is preparing to distribute the Pfizer Inc. / BioNTech SE COVID-19 vaccine this week, amid reports that the government is planning to use military planes to fly in supplies of the vaccine from